In the article titled “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression” [1], reference , J. A. Carlsson et al. [2], was incorrectly included in the reference list and should be replaced with M. F. Roelofs et al. [3].
Corrigendum | Open Access
Corrigendum to “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression”
Received20 Feb 2019
Accepted20 Feb 2019
Published07 Mar 2019
References
Q. Dai, J. Li, Y. Yun, and J. Wang, “Toll-like receptor 4–myeloid differentiation primary response gene 88 pathway is involved in the shikonin treatment of CIA by regulating Treg/Th17 expression,” Evidence-Based Complementary and Alternative Medicine, vol. 2018, Article ID 2428546, 9 pages, 2018.
View at: Publisher Site | Google ScholarJ. A. Carlsson, A. E. Wold, A.-S. Sandberg, and S. M. Östman, “The polyunsaturated fatty acids arachidonic acid and docosahexaenoic acid induce mouse dendritic cells maturation but reduce T-cell responses in vitro,” PLoS ONE, vol. 10, no. 11, Article ID e0143741, 2015.
View at: Publisher Site | Google ScholarM. F. Roelofs, L. A. B. Joosten, S. Abdollahi-Roodsaz et al., “The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells,” Arthritis & Rheumatology, vol. 52, no. 8, pp. 2313–2322, 2005.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2019 Qiaomei Dai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.